Hims & Hers Health (NYSE:HIMS) shares were on a massive run, but that momentum hit a wall recently. Since its peak on ...

Discover why Hims & Hers faces steep corrections amid GLP-1 headwinds and valuation concerns, despite promising FY2024 growth ...

Share on Pinterest Hims and Roman are telemedicine brands that provide quick shipping and discreet delivery for treatments for erectile dysfunction (ED), premature ejaculation (PE), and other ...

Shares of direct-to-consumer healthcare platform Hims & Hers (HIMS) raced 60% higher over the past week after a successful Super Bowl ad, despite lingering disappointment over its earnings report.

Shares in telehealth business Hims & Hers Health (HIMS) dropped over 6% today after reports that it and peers are marketing ...

Hims & Hers (HIMS) stock is sinking 20% today after Eli Lilly (LLY) unveiled significantly cheaper versions of its popular weight-loss drugs today. Additionally, the FDA last week hindered the ...

Shares of Hims & Hers Health (NASDAQ:HIMS) continued to meltdown Tuesday in noontime trading after the direct-to-consumer healthcare platform said it couldn’t guarantee it would be able to ...

Hims Hard Mints are a discreet alternative to erectile dysfunction pills. They’re created by a process called compounding. Compounded medications are customized or altered to meet a specific ...

In this article, we are going to take a look at where Hims & Hers Health, Inc. (NYSE:HIMS) stands against the other skincare stocks. According to NielsenIQ, the global beauty market is expected to ...

HIMS stock is going bananas with the stock up nearly 200% YTD at one point. However, the stock sold off due to the FDA's announcement that semaglutide will be taken off the shortage list. While ...